The Ethos Podcast - What is the point of having company signatories?
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
The Ethos Podcast - What is the point of having company signatories?
-
ナレーター：
-
著者：
このコンテンツについて
Ethos Podcast: Do Companies Still Need Signatories in Pharma Compliance?
This episode of the Ethos Pharmaceutical Ethics & Compliance Podcast explores a key question in the pharmaceutical industry: What is the point of having company signatories in today’s compliance landscape?
With compliance reviews increasingly outsourced to specialist agencies and AI-powered tools becoming more common, we ask whether in-house expertise is still essential.
Hosted by Dr Nick Broughton with guests Dr Ravi Pawa and Dr Sheuli Porkess, this discussion covers:
-
The business case for maintaining in-house expertise
-
Why accountability matters in compliance decisions
-
The limitations of AI in compliance and ethics
-
How effective oversight depends on subject-matter knowledge
This is a must-listen for anyone working in:
-
Pharmaceutical compliance
-
Ethics and regulation
-
ABPI code of practice
-
AI and compliance technologies
🔗 Watch the full discussion and subscribe for future episodes on pharmaceutical ethics, compliance best practices, and the evolving role of signatories in the life sciences industry.